Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026)
Akebia Therapeutics' (AKBA) quarterly Prepaid Assets came in at $3.6 million in Q1 2026, down 60.59% year-on-year from $9.1 million in Q1 2025, and down 34.17% on a QoQ basis from $5.5 million in Q4 2025.
Akebia Therapeutics (AKBA) Prepaid Assets (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has 14 years of Prepaid Assets data on file, last reported at $3.6 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 60.59% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $3.6 million, a 60.59% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, down 51.81% from the prior year.
- Prepaid Assets for Q1 2026 stood at $3.6 million, down from $5.5 million in the prior quarter.
- Over the last five years, Prepaid Assets for AKBA reached as high as $42.1 million in Q2 2022 and fell as low as $3.6 million in Q1 2026.
- Historically, Prepaid Assets has averaged $16.9 million across 5 years, with a median of $13.4 million in 2024.
- Across the five-year window, Prepaid Assets soared 276.79% in 2022 and plunged 82.49% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $32.9 million in 2022, then plunged by 82.49% to $5.8 million in 2023, then soared by 97.25% to $11.4 million in 2024, then sank by 51.81% to $5.5 million in 2025, then slumped by 34.17% to $3.6 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $3.6 million in Q1 2026, $5.5 million in Q4 2025, and $7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Akebia Therapeutics | 325.80 Mn | 163.20 Mn | 41.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 7.83 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Sep 30, 2024 | 13.44 Mn |
| Jun 30, 2024 | 18.96 Mn |
| Mar 31, 2024 | 4.81 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 22.04 Mn |
| Jun 30, 2023 | 24.40 Mn |
| Mar 31, 2023 | 24.70 Mn |
| Dec 31, 2022 | 32.86 Mn |
| Sep 30, 2022 | 28.94 Mn |
| Jun 30, 2022 | 42.13 Mn |
| Mar 31, 2022 | 24.12 Mn |
| Dec 31, 2021 | 33.14 Mn |
| Sep 30, 2021 | 39.50 Mn |
| Jun 30, 2021 | 11.18 Mn |